Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 5
Submit an article Journal homepage
2,037
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

Etienne Giroux LeprieurDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, France;EA4340, Biomarqueursen Cancérologie et Onco-Hématologie, UVSQ, Paris-Saclay University, Boulogne-Billancourt, FranceCorrespondence[email protected]
View further author information
,
Guillaume HerbretauINSERM UMR-S1147, CNRS SNC 5014, Saints-Pères Research Center, 45 rue des Saints-Pères Paris-Descartes University, Sorbonne Paris Cité University, Paris, France;Department of Molecular Biology, Georges Pompidou European Hospital, 20 rue Leblanc, Assistance Publique-Hôpitaux de Paris, Paris, FranceView further author information
,
Coraline DumenilDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Catherine JulieEA4340, Biomarqueursen Cancérologie et Onco-Hématologie, UVSQ, Paris-Saclay University, Boulogne-Billancourt, France;Department of Pathology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Violaine GiraudDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Sylvie LabruneDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Jennifer DumoulinDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Julie TisserandEA4340, Biomarqueursen Cancérologie et Onco-Hématologie, UVSQ, Paris-Saclay University, Boulogne-Billancourt, France;Department of Pathology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Jean-François EmileEA4340, Biomarqueursen Cancérologie et Onco-Hématologie, UVSQ, Paris-Saclay University, Boulogne-Billancourt, France;Department of Pathology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, FranceView further author information
,
Hélène BlonsINSERM UMR-S1147, CNRS SNC 5014, Saints-Pères Research Center, 45 rue des Saints-Pères Paris-Descartes University, Sorbonne Paris Cité University, Paris, France;Department of Molecular Biology, Georges Pompidou European Hospital, 20 rue Leblanc, Assistance Publique-Hôpitaux de Paris, Paris, FranceView further author information
&
Thierry ChinetDepartment of Respiratory Diseases and Thoracic Oncology, APHP – Ambroise Pare Hospital, Boulogne-Billancourt, France;EA4340, Biomarqueursen Cancérologie et Onco-Hématologie, UVSQ, Paris-Saclay University, Boulogne-Billancourt, FranceView further author information
 show all
Article: e1424675 | Received 14 Nov 2017, Accepted 03 Jan 2018, Published online: 29 Jan 2018

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Maria Concetta Nigro, Paola Valeria Marchese, Chiara Deiana, Chiara Casadio, Linda Galvani, Alessandro Di Federico & Andrea De Giglio. (2023) Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review. Lung Cancer: Targets and Therapy 14, pages 11-25.
Read now
Xuezheng Sun, Page Abrahamson, Nicholas Ballew, Linda Kalilani, Kelesitse Phiri, Kelly F. Bell, Alexander Slowley, Magdalena Zajac, Erin Hofstatter, Alexander Stojadinovic, Angela Silvestro, Zebin Wang, Amine Aziez & Solange Peters. (2023) The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies. Cancer Investigation 41:6, pages 571-592.
Read now
David Hsiehchen, Magdalena Espinoza, David E. Gerber & Muhammad S. Beg. (2021) Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay. Cancer Biology & Therapy 22:7-9, pages 455-464.
Read now
Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Naoko Katsurada, Motoko Tachihara, Kazuyuki Kobayashi & Yoshihiro Nishimura. (2019) Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study. OncoTargets and Therapy 12, pages 10559-10568.
Read now
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib & Rafael Rosell. (2019) Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy. Expert Opinion on Biological Therapy 19:5, pages 457-467.
Read now
Adrien Costantini, Catherine Julie, Coraline Dumenil, Zofia Hélias-Rodzewicz, Julie Tisserand, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Jean-François Emile & Etienne Giroux Leprieur. (2018) Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab. OncoImmunology 7:8.
Read now

Articles from other publishers (49)

Jeffrey C. Thompson, Dylan G. Scholes, Erica L. Carpenter & Charu Aggarwal. (2023) Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors. British Journal of Cancer 129:12, pages 1893-1902.
Crossref
Susana Torres‐Martínez, Silvia Calabuig‐Fariñas, Andrea Moreno‐Manuel, Giulia Bertolini, Alejandro Herreros‐Pomares, Eva Escorihuela, Elena Duréndez‐Saéz, Ricardo Guijarro, Ana Blasco, Luca Roz, Carlos Camps & Eloisa Jantus‐Lewintre. (2023) Soluble galectin‐3 as a microenvironment‐relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma. Molecular Oncology.
Crossref
Christopher Grant, Garo Hagopian & Misako Nagasaka. (2023) Neoadjuvant therapy in non-small cell lung cancer. Critical Reviews in Oncology/Hematology 190, pages 104080.
Crossref
Wenwen Wang, Zhiyao Zheng & Jianyong Lei. (2023) CTC, ctDNA, and Exosome in Thyroid Cancers: A Review. International Journal of Molecular Sciences 24:18, pages 13767.
Crossref
Robyn Stanley, Saoirse Flanagan, David O’ Reilly, Ella Kearney, Jarushka Naidoo & Catríona M. Dowling. (2023) Immunotherapy through the Lens of Non-Small Cell Lung Cancer. Cancers 15:11, pages 2996.
Crossref
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki Raby, Véronique Dalstein, Anne Durlach, Maxime Dewolf, Christine Gilles, Myriam Polette & Gaëtan Deslée. (2023) Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors. Frontiers in Immunology 14.
Crossref
Ying Yang, Hongyang Liu, Youming Chen, Nan Xiao, Zhaoyang Zheng, Hongchun Liu & Junhu Wan. (2023) Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives. Cell Death & Disease 14:3.
Crossref
Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard, Lotte Victoria Rogg, Nina Helbekkmo, Bjørn Henning Grønberg, Tarje Onsøien Halvorsen, Christina Ramberg, Vilde Drageset Haakensen, Åsa Kristina Öjlert, Maria Moksnes Bjaanæs & Åslaug Helland. (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT ‐1 trial . Molecular Oncology 17:3, pages 487-498.
Crossref
Kah Yee Goh, Terence You De Cheng, Su Chin Tham & Darren Wan-Teck Lim. (2023) Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC. Biomedicines 11:2, pages 508.
Crossref
Laith Al-Showbaki, Brooke Wilson, Faris Tamimi, Consolacion Molto, Abhenil Mittal, David W Cescon & Eitan Amir. (2023) Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review. Journal for ImmunoTherapy of Cancer 11:2, pages e005854.
Crossref
Léa Sinoquet, William Jacot, Xavier Quantin & Catherine Alix-Panabières. (2023) Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer. Clinical Chemistry 69:1, pages 23-40.
Crossref
Houssein Safa, Fawzi Abu Rous, Neel Belani, Hossein Borghaei, Shirish Gadgeel & Balazs Halmos. (2022) Emerging Biomarkers in Immune Oncology to Guide Lung Cancer Management. Targeted Oncology 18:1, pages 25-49.
Crossref
Jianghao Ren & Ruijun Liu. 2023. Liquid Biopsies. Liquid Biopsies 145 163 .
Malene S. Frank, Christina S.A. Andersen, Lise B. Ahlborn, Niels Pallisgaard, Uffe Bodtger & Julie Gehl. (2022) Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer. Cancer Research Communications 2:10, pages 1174-1187.
Crossref
Rachel J. Keogh & John C. Riches. (2022) The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?. Current Oncology 29:10, pages 7355-7378.
Crossref
Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, Amelia Insa, M. Rosario García-Campelo, Joaquín Casal Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López VivancoEdel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Eva Pereira, Ana Royuela, Virginia Calvo, Javier Martín-López, Francisco García-García, Marta Casarrubios, Fernando Franco, Estela Sánchez-Herrero, Bartomeu Massuti, Alberto Cruz-Bermúdez & Atocha Romero. (2022) Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial). Journal of Clinical Oncology 40:25, pages 2924-2933.
Crossref
Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, Michael R Bishop, Daniel S Chen, Madhav Dhodapkar, Leisha A Emens, Marc S Ernstoff, Robert L Ferris, Tim F Greten, James L Gulley, Roy S Herbst, Rachel W Humphrey, James Larkin, Kim A Margolin, Luca Mazzarella, Suresh S Ramalingam, Meredith M Regan, Brian I Rini & Mario Sznol. (2022) Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Journal for ImmunoTherapy of Cancer 10:9, pages e005413.
Crossref
Hylke C. Donker, Ed Schuuring, Ellen Heitzer & Harry J.M. Groen. (2022) Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer. Lung Cancer 170, pages 52-57.
Crossref
Estela Sánchez-Herrero, Roberto Serna-Blasco, Lucia Robado de Lope, Víctor González-Rumayor, Atocha Romero & Mariano Provencio. (2022) Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis. Frontiers in Oncology 12.
Crossref
Joanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, Darryl Irwin, Gunter Hartel, Majid Ebrahimi Warkiani, Paul Leo, Connor O'Leary, Rahul Ladwa, Kenneth O'Byrne, Brett G.M. Hughes & Chamindie Punyadeera. (2022) Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon 8:7, pages e09971.
Crossref
Frank Rojas, Edwin Roger Parra, Ignacio Ivan Wistuba, Cara Haymaker & Luisa Maren Solis Soto. (2022) Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors. Cancers 14:11, pages 2775.
Crossref
Ana Oitabén, Pablo Fonseca, María J. Villanueva, Carme García-Benito, Aida López-López, Alberto Garrido-Fernández, Clara González-Ojea, Laura Juaneda-Magdalena, Martín E. Lázaro & Mónica Martínez-Fernández. (2022) Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. Cancers 14:11, pages 2626.
Crossref
Pashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, Michael Krainock, Andrew Poklepovic, George Ansstas, Minu Maninder, Meenakshi Malhotra, Joe Ensor, Ling Gao, Zeynep Eroglu, Sascha Ellers, Paul Billings, Angel Rodriguez & Alexey Aleshin. (2022) BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours. BMJ Open 12:5, pages e060342.
Crossref
E. Heitzer, D. van den Broek, M.G. Denis, P. Hofman, M. Hubank, F. Mouliere, L. Paz-Ares, E. Schuuring, H. Sültmann, G. Vainer, E. Verstraaten, L. de Visser & D. Cortinovis. (2022) Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer. ESMO Open 7:2, pages 100399.
Crossref
Ning Zhang, Yifeng Liao, Weize Lv, Shunda Zhu, Yeqing Qiu, Nan Chen, Mei Xiao & Hongyu Zhang. (2022) FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer. Cellular Oncology 45:2, pages 293-307.
Crossref
Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, Mark Sementsov, Isabel Heidrich, Christoffer Gebhardt, Laura Keller & Klaus Pantel. (2022) Current and Future Clinical Applications of ctDNA in Immuno-Oncology. Cancer Research 82:3, pages 349-358.
Crossref
Ranjana Nagi, Jeeyun A. Kim, Shubhdeep Nagi & Christine Y. Lu. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy 1 16 .
Patricia Mondelo‐Macía, Jorge García‐González, Luis León‐Mateos, Urbano Anido, Santiago Aguín, Ihab Abdulkader, María Sánchez‐Ares, Alicia Abalo, Aitor Rodríguez‐Casanova, Ángel Díaz‐Lagares, Ramón Manuel Lago‐Lestón, Laura Muinelo‐Romay, Rafael López‐López & Roberto Díaz‐Peña. (2021) Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab. Molecular Oncology 15:11, pages 2923-2940.
Crossref
Nikhil Shukla, Nasser Hanna & Greg Durm. (2021) Optimal Duration of Maintenance Checkpoint Inhibitor Therapy in Patients With Advanced NSCLC. JCO Oncology Practice 17:8, pages 472-474.
Crossref
Marie Wislez, Charlotte Domblides, Laurent Greillier, Julien Mazières, Isabelle Monnet, Lize Kiakouama-Maleka, Xavier Quantin, Jean Philippe Spano, Charles Ricordel, Philippe Fraisse, Henri Janicot, Clarisse Audigier-Valette, Elodie Amour, Alexandra Langlais, Nathalie Rabbe, Alain Makinson, Jacques Cadranel, Pierre Laurent-Puig, Armelle Lavolé & Hélène Blons. (2021) Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA). Lung Cancer 157, pages 124-130.
Crossref
Elena María Brozos-Vázquez, Roberto Díaz-Peña, Jorge García-González, Luis León-Mateos, Patricia Mondelo-Macía, María Peña-Chilet & Rafael López-López. (2020) Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy. Cancer Immunology, Immunotherapy 70:5, pages 1177-1188.
Crossref
Elien Augustus, Karen Zwaenepoel, Vasiliki Siozopoulou, Jo Raskin, Stephanie Jordaens, Geert Baggerman, Laure Sorber, Geert Roeyen, Marc Peeters & Patrick Pauwels. (2021) Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle. Cancers 13:7, pages 1675.
Crossref
Zhuonan Ran, Jiexing Liu, Fen Wang, Caiyan Xin, Bin Xiong & Zhangyong Song. (2021) Pulmonary Micro-Ecological Changes and Potential Microbial Markers in Lung Cancer Patients. Frontiers in Oncology 10.
Crossref
Jiaping Li, Wei Jiang, Jinwang Wei, Jianwei Zhang, Linbo Cai, Minjie Luo, Zhan Wang, Wending Sun, Shengzhou Wang, Chen Wang, Chun Dai, Jun Liu, Guan Wang, Jiping Wang, Qiang Xu & Yanhong Deng. (2020) Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors. Journal of Translational Medicine 18:1.
Crossref
Andreas Hallqvist, Anna Rohlin & Sukanya Raghavan. (2020) Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer. Scandinavian Journal of Immunology 92:6.
Crossref
Silvia M. Bacot, Taylor A. Harper, Rebecca L. Matthews, Christie Jane Fennell, Adovi Akue, Mark A. KuKuruga, Shiowjen Lee, Tao Wang & Gerald M. Feldman. (2020) Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy. International Journal of Molecular Sciences 21:23, pages 9023.
Crossref
Sheena Bhalla, Deborah Blythe Doroshow & Fred R. Hirsch. (2020) Predictive Biomarkers for Immune Checkpoint Inhibitors in Advanced Non–Small Cell Lung Cancer. The Cancer Journal 26:6, pages 507-516.
Crossref
Scott V. Bratman, S. Y. Cindy Yang, Marco A. J. Iafolla, Zhihui Liu, Aaron R. Hansen, Philippe L. Bedard, Stephanie Lheureux, Anna Spreafico, Albiruni Abdul Razak, Svetlana Shchegrova, Maggie Louie, Paul Billings, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Dax Torti, Kayla Marsh, Jenna Eagles, Iulia Cirlan, Youstina Hanna, Derek L. Clouthier, Scott C. Lien, Pamela S. Ohashi, Wei Xu, Lillian L. Siu & Trevor J. Pugh. (2020) Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab. Nature Cancer 1:9, pages 873-881.
Crossref
Stepan M. Esagian, Georgia Ι. Grigoriadou, Ilias P. Nikas, Vasileios Boikou, Peter M. Sadow, Jae-Kyung Won & Konstantinos P. Economopoulos. (2020) Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review. Journal of Cancer Research and Clinical Oncology 146:8, pages 2051-2066.
Crossref
Luka de Vos, Maria Jung, Ruth-Miriam Koerber, Emma G. Bawden, Tobias A.W. Holderried, Jörn Dietrich, Friedrich Bootz, Peter Brossart, Glen Kristiansen & Dimo Dietrich. (2020) Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood. The Journal of Molecular Diagnostics 22:7, pages 920-933.
Crossref
Sunhee Chang, Jae Young Hur, Yoon-La Choi, Chang Hun Lee & Wan Seop Kim. (2020) Current status and future perspectives of liquid biopsy in non-small cell lung cancer. Journal of Pathology and Translational Medicine 54:3, pages 204-212.
Crossref
Qingzhu Jia, Luting Chiu, Shuangxiu Wu, Jian Bai, Lina Peng, Linpeng Zheng, Rui Zang, Xueqin Li, Bibo Yuan, Yixing Gao, Dingyong Wu, Xiaohong Li, Lin Wu, Jianguo Sun, Ji He, Bruce W. S. Robinson & Bo Zhu. (2020) Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer. Advanced Science 7:9.
Crossref
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Giacomo Vallome, Claudio Sini, Massimiliano Grassi, Maria Giovanna Dal Bello, Simona Coco, Luca Longo, Lodovica Zullo, Enrica Teresa Tanda, Chiara Dellepiane, Paolo Pronzato & Carlo Genova. (2020) Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers 12:5, pages 1125.
Crossref
Aleksandra Filipovic, George Miller & Joseph Bolen. (2020) Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies. Frontiers in Cell and Developmental Biology 8.
Crossref
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Giacomo Vollome, Claudio Sini, Massimiliano Grassi, Maria Giovanna Dal Bello, Simona Coco, Luca Longo, Lodovica Zullo, Enrica Teresa Tanda, Chiara Dellepiane, Paolo Pronzato & Carlo Genova. (2020) Präzisionsmedizin bei NSCLC im Zeitalter der Immuntherapie: Neue Biomarker zur Selektion der am besten geeigneten Therapie oder des am besten geeigneten Patienten. Kompass Pneumologie 8:6, pages 300-317.
Crossref
Adrien Costantini, Paul Takam Kamga, Coraline Dumenil, Thierry Chinet, Jean-François Emile & Etienne Giroux Leprieur. (2019) Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?. Cancers 11:9, pages 1269.
Crossref
Alama, Coco, Genova, Rossi, Fontana, Tagliamento, Giovanna Dal Bello, Rosa, Boccardo, Rijavec, Biello, Longo, Cavalieri, Bruzzo & Grossi. (2019) Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine 8:7, pages 1011.
Crossref
Luis M. Seijo, Nir Peled, Daniel Ajona, Mattia Boeri, John K. Field, Gabriella Sozzi, Ruben Pio, Javier J. Zulueta, Avrum Spira, Pierre P. Massion, Peter J. Mazzone & Luis M. Montuenga. (2019) Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. Journal of Thoracic Oncology 14:3, pages 343-357.
Crossref
Luc Cabel, Charlotte Proudhon, Emanuela Romano, Nicolas Girard, Olivier Lantz, Marc-Henri Stern, Jean-Yves Pierga & François-Clément Bidard. (2018) Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy. Nature Reviews Clinical Oncology 15:10, pages 639-650.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.